1. Home
  2. RYTM vs PRM Comparison

RYTM vs PRM Comparison

Compare RYTM & PRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rhythm Pharmaceuticals Inc.

RYTM

Rhythm Pharmaceuticals Inc.

HOLD

Current Price

$93.66

Market Cap

5.8B

Sector

Health Care

ML Signal

HOLD

Logo Perimeter Solutions SA

PRM

Perimeter Solutions SA

HOLD

Current Price

$35.56

Market Cap

4.9B

ML Signal

HOLD

Company Overview

Basic Information
Metric
RYTM
PRM
Founded
2008
2018
Country
United States
United States
Employees
N/A
371
Industry
Biotechnology: Pharmaceutical Preparations
Newspapers/Magazines
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
5.8B
4.9B
IPO Year
2017
N/A

Fundamental Metrics

Financial Performance
Metric
RYTM
PRM
Price
$93.66
$35.56
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
14
2
Target Price
$131.14
$27.50
AVG Volume (30 Days)
555.5K
1.2M
Earning Date
05-05-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
28.34
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$55.34
$30.45
Revenue Next Year
$86.06
$8.44
P/E Ratio
N/A
$51.56
Revenue Growth
N/A
N/A
52 Week Low
$60.99
$13.16
52 Week High
$122.20
$36.95

Technical Indicators

Market Signals
Indicator
RYTM
PRM
Relative Strength Index (RSI) 62.82 64.69
Support Level $82.43 $30.08
Resistance Level $100.69 N/A
Average True Range (ATR) 4.46 1.29
MACD 0.64 0.39
Stochastic Oscillator 81.49 81.01

Price Performance

Historical Comparison
RYTM
PRM

About RYTM Rhythm Pharmaceuticals Inc.

Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company engaged in the development and commercialization of therapies for patients with rare neuroendocrine diseases. The company is focused on advancing its melanocortin-4 receptor (MC4R) agonists, including its main asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. In addition, it has two early-stage investigational MC4R agonists in clinical development, RM-718 and bivamelagon, designed not to cause hyperpigmentation. The company is also focused on advancing potential candidates for congenital hyperinsulinism. It currently operates in two business segments: the United States, which generates maximum revenue, and International.

About PRM Perimeter Solutions SA

Perimeter Solutions Inc is a solutions provider for the Fire Safety and Specialty Products industries. The company's products and operations are managed and reported in two operating segments. Its Fire Safety segment provides fire retardants and firefighting foams, as well as specialized equipment and services typically offered in conjunction with the company's retardant and foam products. The Specialty Products segment develops, produces, and markets phosphorus pentasulfide (P2S5)-based products used in lubricant additives, as well as in pesticide, mining chemical, and battery applications.

Share on Social Networks: